Nuveen Asset Management, LLC Nurix Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 673,554 shares of NRIX stock, worth $13.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

673,554

Previous 981,167 31.35%

Holding current value

$13.4 Million

Previous $20.5 Million 26.15%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$18.93 - $25.69 $5.82 Million - $7.9 Million	-307,613 Reduced 31.35%	673,554 $15.1 Million
Q2 2024 Aug 09, 2024	BUY	$12.02 - $21.3 $6.76 Million - $12 Million	562,344 Added 134.27%	981,167 $20.5 Million
Q1 2024 May 13, 2024	SELL	$7.77 - $15.66 $893,876 - $1.8 Million	-115,042 Reduced 21.55%	418,823 $6.16 Million
Q4 2023 Feb 14, 2024	SELL	$4.25 - $10.71 $549,928 - $1.39 Million	-129,395 Reduced 19.51%	533,865 $5.51 Million
Q3 2023 Nov 14, 2023	SELL	$7.86 - $10.08 $32,674 - $41,902	-4,157 Reduced 0.62%	663,260 $5.21 Million
Q2 2023 Aug 14, 2023	SELL	$8.7 - $13.28 $22,237 - $33,943	-2,556 Reduced 0.38%	667,417 $6.67 Million
Q1 2023 May 15, 2023	SELL	$8.56 - $13.26 $174,555 - $270,397	-20,392 Reduced 2.95%	669,973 $5.95 Million
Q4 2022 Feb 14, 2023	BUY	$9.86 - $14.59 $1.36 Million - $2.01 Million	137,709 Added 24.92%	690,365 $7.58 Million
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $2.81 Million - $4.52 Million	228,071 Added 70.27%	552,656 $7.2 Million
Q2 2022 Aug 15, 2022	BUY	$7.88 - $14.82 $1.73 Million - $3.25 Million	219,194 Added 207.98%	324,585 $4.11 Million
Q1 2022 May 16, 2022	BUY	$12.94 - $29.65 $137,345 - $314,705	10,614 Added 11.2%	105,391 $1.44 Million
Q4 2021 Feb 14, 2022	SELL	$26.43 - $34.5 $187,177 - $244,329	-7,082 Reduced 6.95%	94,777 $2.49 Million
Q3 2021 Nov 12, 2021	SELL	$22.71 - $36.69 $1.07 Million - $1.72 Million	-46,900 Reduced 31.53%	101,859 $3.67 Million
Q2 2021 Aug 16, 2021	BUY	$24.21 - $35.89 $210,675 - $312,314	8,702 Added 6.21%	148,759 $3.95 Million
Q1 2021 May 17, 2021	BUY	$26.98 - $50.17 $1.11 Million - $2.07 Million	41,216 Added 41.7%	140,057 $4.35 Million
Q4 2020 Feb 16, 2021	BUY	$22.85 - $48.44 $730,994 - $1.55 Million	31,991 Added 47.85%	98,841 $3.25 Million
Q3 2020 Nov 16, 2020	BUY	$16.05 - $34.91 $1.07 Million - $2.33 Million	66,850 New	66,850 $2.33 Million

Others Institutions Holding NRIX

# of Institutions

181

Shares Held

68.1M

Call Options Held

78K

Put Options Held

53.8K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $935M
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Nurix Therapeutics, Inc. Transaction History